Centre for Immunology of Bordeaux

Centre for Immunology of Bordeaux
Name	Centre for Immunology of Bordeaux
Established	1990s
Type	Public research institute
City	Bordeaux
Country	France
Affiliations	Université de Bordeaux, Inserm, CNRS

Centre for Immunology of Bordeaux is a multidisciplinary research institute located in Bordeaux focused on immunology, inflammation, infection, and translational medicine. The institute integrates teams from national organizations such as Inserm, CNRS, and Université de Bordeaux to bridge basic science and clinical application. It has contributed to programs linking regional hospitals like Hôpital Pellegrin and international initiatives involving institutions such as Institut Pasteur and Imperial College London.

History

The institute traces origins to collaborations among Université de Bordeaux, CNRS laboratories, and clinical services at CHU de Bordeaux during the late 20th century, influenced by European Union frameworks like the Framework Programmes for Research and Technological Development and funding bodies including ANR (Agence Nationale de la Recherche). Key historical moments involved partnerships with Institut Pasteur, bilateral agreements with National Institutes of Health exchanges, and participation in networks such as EMBO and European Molecular Biology Laboratory. Leadership transitions referenced figures associated with Inserm initiatives and regional development plans promoted by Nouvelle-Aquitaine authorities.

Organization and Research Units

The organizational structure comprises mixed units (UMRs) and Inserm teams co-affiliated with CNRS and Université de Bordeaux, organized into thematic groups corresponding to clinical departments at Hôpital Pellegrin, research centers like Bordeaux Neurocampus, and translational platforms partnered with Groupement Hospitalier Universitaire (GHU). Units emphasize interactions with laboratories from Institut Curie, Centre national de la recherche scientifique, and departments tied to Collège de France visiting collaborations. Administrative governance has engaged oversight from bodies such as Ministry of Higher Education, Research and Innovation (France), regional councils, and international review panels including members from Wellcome Trust and Scientific Advisory Boards featuring scholars from Harvard Medical School, University of Oxford, and Max Planck Society.

Research Focus and Programs

Research programs span innate immunity, adaptive immunity, mucosal immunology, tumor immunology, vaccine development, and autoimmunity, often aligned with clinical trials at Hôpital Saint-André and consortia such as Innovative Medicines Initiative and European Research Council grants. Projects investigate cytokine signaling pathways linked to discoveries from laboratories like Weizmann Institute of Science and Salk Institute, host–microbe interactions studied alongside teams at Wageningen University and Johns Hopkins University, and immunometabolism influenced by collaborations with Imperial College London and Stanford University School of Medicine. The center has participated in multicenter studies involving World Health Organization frameworks, comparative immunology with Max Planck Institute for Immunobiology and Epigenetics, and translational vaccine platforms inspired by technologies from Moderna and BioNTech collaborations.

Facilities and Core Technologies

Core facilities include flow cytometry platforms comparable to services at EMBL, high-throughput sequencing units following standards of Broad Institute, advanced microscopy suites akin to European Molecular Biology Laboratory resources, and proteomics labs in collaboration with Institut Curie mass spectrometry groups. Biobanks operate under governance models like BBMRI-ERIC, and animal facilities comply with regulations referenced by European Commission directives, enabling preclinical models similar to those used at The Francis Crick Institute. Computational biology and bioinformatics cores support projects using infrastructure concepts from CNRS National Computing Center and cloud partnerships with providers used by European Open Science Cloud initiatives.

Collaborations and Partnerships

The institute maintains partnerships with universities including Université de Bordeaux, University of Cambridge, McGill University, Karolinska Institutet, and industry partners such as Sanofi, GSK, Roche, and biotech firms modeled on Genentech and CureVac. It participates in European networks like ERINHA and EATRIS and global consortia including projects linked to GAVI, the Vaccine Alliance and CEPI. Collaborative clinical research has been performed with hospitals such as Hôpital Européen Georges-Pompidou and international research centers like National Institute of Allergy and Infectious Diseases. Funding and collaborative frameworks have included grants from European Commission Horizon 2020, private philanthropy akin to Bill & Melinda Gates Foundation, and national programmes sponsored by Inserm.

Education and Training

The center contributes to graduate programs at Université de Bordeaux, postgraduate training with Inserm School of Doctoral Studies, and international exchange schemes with Erasmus+, Marie Skłodowska-Curie Actions, and visiting scholar programs drawing academics from Yale School of Medicine, Columbia University Irving Medical Center, and University of California, San Francisco. It organizes workshops and courses featuring faculty from EMBO, guest lecturers from Harvard Medical School, and summer schools modeled on those at Cold Spring Harbor Laboratory.

Awards and Notable Achievements

Teams have secured competitive funding from European Research Council grants, ANR awards, and collaborative contracts with pharmaceutical partners such as Sanofi Pasteur. Publications have appeared in journals associated with Nature Publishing Group, Cell Press, and The Lancet, and researchers have been recognized by societies such as European Federation of Immunological Societies and honors paralleling Légion d'Honneur recipients in regional scientific communities. The institute’s translational outputs have informed clinical protocols at CHU de Bordeaux and contributed to policy discussions in forums like WHO advisory groups.

Category:Research institutes in France